Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
1347 Views
eMediNexus 18 January 2023
Nearly 70 million patients suffer from epilepsy globally. Antiepileptic drugs, when used for a longer duration can alter the bone tissue and its metabolism, thus raising the risk of fractures. Clinical and pre-clinical studies have rendered inconsistent data regarding the use of pregabalin as a new antiepileptic drug. A recent study thus investigated its cytotoxicity in primary human osteoblasts (hOB).
HOB and human mesenchymal stem cells (hMSC) were sequestered from patients and the human osteosarcoma cells MG63 were contained as an established cell line. Further, the cells were incubated with pregabalin at concentrations ranging from 0 to 40 μg/mL. Automatic cell counting measured Time-dependent cell proliferation, XTT assay measured metabolism and alkaline phosphatase (ALP) activity measured osseous differentiation. Calcium deposits were evaluated histologically employing ALP, Alizarin Red, and von Kossa staining.
Thus, contrasting to other antiepileptic drugs, pregabalin demonstrated no osteocatabolic effects.
Source: Cells. Life. 2022; 12(4):496. https://doi.org/10.3390/life12040496
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}..
High 1-hour Plasma Glucose: Early Indicator of Type 2 Diabetes Risk..
Maintaining Liver Health to Optimize Glycemic Outcomes in Early Type 2.....
Hidden Hazard of Indoor Pollution in COPD..
Antibiotic Prescribing Practices for Pediatric Acute Otitis Media..
Recognizing Pitfalls of Point-of-Care Lung Ultrasound..